| Ganglioside nomenclature is in accordance with IUPAC-IUBB recommendations [58] | |
| αS | alpha-synuclein |
| Akt | RAC-alpha serine/threonine-protein kinase |
| BBB | Blood–brain barrier |
| BSA | bovine serum albumin |
| BDNF | brain-derived neurotrophic factor |
| CGN | cerebellar granule neurons |
| CMF-PBS | calcium magnesium free-PBS |
| CNS | central nervous system |
| CTRL | control |
| DA | dopamine |
| DAPI | 4′,5-diamina-2-phenylindole |
| DAT | DA transporter |
| DMEM | Dulbecco’s modified Eagles’ medium |
| EDTA | ethylenediaminetetraacetic acid |
| FBS | fetal bovine serum |
| FCS | fetal calf serum |
| GDNF | glial-derived neurotrophic factor |
| GM1 | II3Neu5Ac-Gg4Cer, β-Gal-(1-3)-β-GalNAc-(1-4)-[α-Neu5Ac-(2-3)]-β-Gal-(1-4)-β-Glc-Cer |
| GM1-OS | GM1-oligosaccharide, II3Neu5Ac-Gg4, β-Gal-(1-3)-β-GalNAc-(1-4)-[α-Neu5Ac-(2-3)]-β-Gal-(1-4)-Glc |
| GSK-3β | glycogen synthase kinase-3β |
| HBSS | Hanks’ balanced salt solution |
| HPR | horseradish peroxidase |
| IHC | immunohistochemistry |
| IL-6 | interleukin 6 |
| IP | Protease inhibitor cocktail |
| LDH | lactate dehydrogenase |
| MAPK | mitogen-activated protein kinase |
| MPTP | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrocholoride |
| MPP+ | 1-methyl-4-phenylpyridinium |
| mTORs | mammalian target of rapamycin |
| MTT | 3-(4,5,-dimethylthiazole-2yl)-2,5-diphenyltetrazolium bromide |
| Na3VO4 | sodium orthovanadate |
| O2•- | superoxide |
| p-AKT | phospho-AKT |
| p-GSK-3β | phospho-GSK-3β |
| p-mTOR | phospho-mTOR |
| PBS | phosphate-buffered saline |
| PFA | paraformaldehyde |
| PMSF | phenylmethanesulfonyl fluoride |
| PD | Parkinson’s disease |
| P/S | penicillin and streptomycin |
| PVDF | polyvinylidene difluoride |
| ROS | reactive oxygen species |
| RRID | research resource identifier |
| SDS | sodium dodecyl sulfate |
| SEM | standard error of the mean |
| Ser | Serine residue |
| SNpc | substantia nigra pars compacta |
| TH | tyrosine hydroxylase |
| TrkA | neurotrophin tyrosin kinase receptor |
| WB | western blot |